Elantas Beck India Ltd
ELANTASElantas Beck India Ltd's earnings have outrun its stock. EPS grew +5.9% in a year against a −33.5% price move.
The sharpest disagreement: annual EPS moved +5.9% against a −33.5% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (4 weeks in) while the P/E sits at the 74th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit −6.1% year on year, and 76% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Elantas Beck India Ltd trades at ₹9,274, in a confirmed uptrend and 4 weeks into that stage. That is −2.9% against its own 200-day average. It sits at 27% of a 52-week range of ₹7,984 to ₹12,696. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 4 of stage 2, confirmed. At ₹9,274 it trades −2.9% versus its 200-day average and sits at 27% of its 52-week range (₹7,984–₹12,696).
Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +622% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 74th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Elantas Beck India Ltd trades at 50.3× P/E, at the pricey end of its own range (74th percentile). Its long-run median P/E is 42.5×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 50.3× is at the pricey end of its own range (74th percentile), against a long-run median of 42.5× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +5.9% against a −33.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +17.7%/yr price move, ~+17.0%/yr came from earnings growth and ~+0.7 pp from the multiple (roughly flat); over 10y, of the +18.2%/yr price move, ~+11.7%/yr came from earnings growth and ~+6.5 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 3.2% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Elantas Beck India Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 21.0% — the per-curve reads carry the story. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +13.2% | +9.5% | +17.2% | +9.4% |
| Profit | +5.7% | +14.7% | +19.0% | +13.4% |
| EPS | +5.9% | +14.8% | +19.1% | +13.5% |
| Share price | −33.5% | +14.7% | +17.7% | +18.2% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
52.2/100 — rank 7 of 20 in Chemicals - Organic · 77% evidence confidence
Elantas Beck India Ltd scores 52.2 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 18.9 + 19.1 + 7 + 7.2 = 52.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Elantas Beck India Ltd reported ₹222 Cr of revenue in the Mar 26 quarter, +7.8% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 9.4% a year. The last full year, FY25, came in at ₹848 Cr. The last four reported quarters add to ₹864 Cr.
Elantas Beck India Ltd reported ₹222 Cr of revenue in the Mar 26 quarter, +7.8% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 9.4% a year. The last full year, FY25, came in at ₹848 Cr. The last four reported quarters add to ₹864 Cr.
FY25 revenue came in at ₹848 Cr (+13.2% on the year), capping 10 years at 9.4% compound. The latest quarter (Mar 26) printed ₹222 Cr, +7.8% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +11.2% growth against the decade's 9.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +11.1% over the last 4 quarters against +12.1%/yr over the last 8 — stabilising; TTM profit +6.6% vs +0.3%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 20.0% this quarter (+0.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Elantas Beck India Ltd's operating margin is 20.0% in the Mar 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 12.0% to 22.0%. The current quarter sits inside that band.
Elantas Beck India Ltd's operating margin is 20.0% in the Mar 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 12.0% to 22.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 20.0%, +0.0 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 12.0%–22.0%.
🚨 Why the margin moved: operating margin went −0.1 pp year on year while gross margin went +3.8 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins held — did that reach the bottom line? Next: profit −6.1% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Elantas Beck India Ltd earned ₹31.0 Cr of net profit in the Mar 26 quarter, −6.1% year on year. Full-year FY25 profit was ₹148 Cr. The 10-year compound rate is 13.4%. That is 14.0% of the quarter's revenue. The same quarter a year earlier earned ₹33.0 Cr.
Elantas Beck India Ltd earned ₹31.0 Cr of net profit in the Mar 26 quarter, −6.1% year on year. Full-year FY25 profit was ₹148 Cr. The 10-year compound rate is 13.4%. That is 14.0% of the quarter's revenue. The same quarter a year earlier earned ₹33.0 Cr.
Mar 26 profit was ₹31.0 Cr, −6.1% year on year. On the full year, FY25 printed ₹148 Cr (+5.7%), and the 10-year compound rate is 13.4%.
🚨 Why profit moved: revenue contributed +7.8% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +8.2% vs revenue +11.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
→ Profit rose — but did the cash follow? Next: 76% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 76% of Elantas Beck India Ltd's reported profit arrived as operating cash — most of the profit is real cash. In FY25 that was ₹127 Cr of operating cash against ₹148 Cr of profit. After ₹27.0 Cr of capital spending, ₹100 Cr was left as free cash.
FY25: operating cash of ₹127 Cr against reported profit of ₹148 Cr, leaving free cash of ₹100 Cr after ₹27.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 76% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 76%: the cash cycle stretched 16 days between FY20 and FY25 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: conversion is below par and the cash cycle has stretched 16 days — the next section's job is to find where the cash is stuck.
→ So follow the cash to where it goes. Next: the 70-day cycle, in money terms.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Elantas Beck India Ltd's cash conversion cycle runs 70 days in FY25, up from 54 days in FY20. Capital spending ran ₹185 Cr over the last 3 years. At FY25 sales of ₹848 Cr each day of that cycle holds about ₹2.3 Cr, so roughly ₹163 Cr sits inside the business at any moment.
FY25: debtors at 60 days, inventory at 71 days — roughly 2.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 70 days, looser than FY20's 54.
The full loop: cash goes out to suppliers and production on day 0; stock waits 71 days to sell; customers pay about 60 days after that; and suppliers themselves are paid at 61 days — netting out to the 70-day cycle.
In money terms: at FY25 sales of ₹848 Cr, each day of the cycle holds about ₹2.3 Cr — so the 70-day loop keeps roughly ₹163 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹185 Cr over the last 3 fiscal years against ₹48.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹8.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 21%.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Elantas Beck India Ltd earns a ROCE of 21% in FY25. That is up from a trough of 17% in FY21. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 17.5% net margin on 0.73× asset turns.
FY25 ROCE is 21%, recovered from a FY21 trough of 17% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 17.5% net margin × 0.73× asset turns × 1.16× balance-sheet leverage ≈ 14.8% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 3.2% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.00.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Elantas Beck India Ltd carries ₹0.0 Cr of borrowings against ₹1,008 Cr of equity in FY25, a debt-to-equity of 0.00. Operating profit covers the interest bill north of 100×. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr. Capital spending ran ₹185 Cr across the last 3 of those years.
FY25: borrowings of ₹0.0 Cr against equity of ₹1,008 Cr — a debt-to-equity of 0.00. Operating profit covers the interest bill north of 100×. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr while capital spending ran ₹185 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
→ Who owns this, and are they adding or leaving? Next: the register is quiet.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Elantas Beck India Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.4 points over the same window, to 12.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.6 points over 8 quarters to 0.1%; Domestic institutions: +0.4 points over 8 quarters to 12.3%; Promoters: +0.0 points over 8 quarters to 75.0%.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Elantas Beck India Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Elantas Beck India Ltd this page | 50.3× | ₹7,346 Cr | Mixed | |||
| BASF India Ltd | 38.4× | ₹15,887 Cr | No read | |||
| Fine Organic Industries Ltd | 35.9× | ₹14,804 Cr | Improving | |||
| Balaji Amines Ltd | 42.2× | ₹7,046 Cr | Improving | |||
| Laxmi Organic Industries Ltd | 63.2× | ₹5,053 Cr | Mixed | |||
| Foseco India Ltd | 39.0× | ₹3,805 Cr | — | — | — | — |
| Citurgia Biochemicals Ltd | — | ₹1,884 Cr | No read | |||
| Nitta Gelatin India Ltd | 13.5× | ₹1,489 Cr | Mixed | |||
| Oriental Aromatics Ltd | 379.0× | ₹1,255 Cr | Mixed | |||
| Jyoti Resins and Adhesives Ltd | 14.3× | ₹997 Cr | Topping out | |||
| Sigachi Industries Ltd | 29.9× | ₹974 Cr | Turning around | |||
| Fairchem Organics Ltd | 157.0× | ₹967 Cr | Turning around | |||
| Sacheerome Ltd | 33.3× | ₹946 Cr | — | — | — | — |
| Indo Amines Ltd | 11.8× | ₹940 Cr | Consistent | |||
| Gem Aromatics Ltd | 651.0× | ₹930 Cr | No read | |||
| Shri Ahimsa Naturals Ltd | 31.1× | ₹904 Cr | — | — | — | — |
| Valiant Organics Ltd | 25.4× | ₹737 Cr | No read | |||
| OCCL Ltd | 14.6× | ₹724 Cr | No read | |||
| Shree Ganesh Remedies Ltd | 35.1× | ₹636 Cr | Deteriorating | |||
| Valiant Organics Ltd | 33.0× | ₹600 Cr | No read | |||
| GFL Ltd | 11.0× | ₹494 Cr | No read |
Frequently asked questions
What is Elantas Beck India Ltd's share price today?
Elantas Beck India Ltd trades at ₹9,274, −33.5% over the past year. The company is valued at ₹7,346 Cr. The stock sits at 27% of its 52-week range of ₹7,984–₹12,696, −2.9% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 4 weeks in. — as of 24 July 2026.
What were Elantas Beck India Ltd's latest quarterly results?
Elantas Beck India Ltd reported revenue of ₹222 Cr and net profit of ₹31.0 Cr for the Mar 26 quarter. Revenue rose 7.8% and profit fell 6.1% year on year. Earnings per share were ₹39.20. The operating margin was 20.0%, 0.0 pp higher than a year earlier. — as of 24 July 2026.
What is Elantas Beck India Ltd's revenue?
Elantas Beck India Ltd reported revenue of ₹222 Cr in the Mar 26 quarter, +7.8% year on year. For the full FY25 fiscal year, revenue was ₹848 Cr (+13.2%). Over the last 10 years revenue compounded at 9.4% a year. — as of 24 July 2026.
What is Elantas Beck India Ltd's profit?
Elantas Beck India Ltd earned ₹31.0 Cr of net profit in the Mar 26 quarter, −6.1% year on year. Full-year FY25 profit was ₹148 Cr. The operating margin ran 20.0% in the latest quarter. — as of 24 July 2026.
What is Elantas Beck India Ltd's market cap?
Elantas Beck India Ltd's market capitalisation is ₹7,346 Cr at a share price of ₹9,274. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is Elantas Beck India Ltd's P/E ratio?
Elantas Beck India Ltd trades at a P/E of 50.3×, at the 74th percentile of its own 10-year range, against a long-run median of 42.5×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does Elantas Beck India Ltd pay a dividend?
Yes — Elantas Beck India Ltd's dividend payout was 4% of profit in FY25, and it recorded a payout in each of its last 12 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is Elantas Beck India Ltd overvalued?
On its own history, Elantas Beck India Ltd looks expensive against its own history: its P/E of 50.3× sits at the 74th percentile of its 10-year range (long-run median 42.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
Is Elantas Beck India Ltd growing?
Yes — Elantas Beck India Ltd is growing: latest-quarter revenue +7.8% year on year, profit −6.1%, and the margin +0.0 pp at 20.0%. The 10-year compound rates are 9.4% (revenue) and 13.4% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is Elantas Beck India Ltd performing?
Elantas Beck India Ltd is in a confirmed uptrend, 4 weeks in. Its latest quarter's revenue rose 7.8% and profit fell 6.1% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is Elantas Beck India Ltd in?
Mixed — no clean majority across the growth curves, ROCE holding at 21.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +7.8% latest, profit growth −6.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is Elantas Beck India Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 4 of stage 2), trading −2.9% versus its 200-day average and at 27% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Elantas Beck India Ltd beating the market?
Not lately — on a trailing-13-week view Elantas Beck India Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +622% against the NIFTY 500's +274% — ahead of the index over the full window. — as of 24 July 2026.
Will Elantas Beck India Ltd's share price go up?
This page publishes no price forecast for Elantas Beck India Ltd. What it measures instead: the share price is ₹9,274, the price is in a confirmed uptrend 4 weeks in. Its P/E of 50.3× sits at the 74th percentile of its own 10-year range. — as of 24 July 2026.
Who owns Elantas Beck India Ltd?
Promoters hold 75.0% of Elantas Beck India Ltd, foreign institutions 0.1%, domestic institutions 12.3% and the public 12.7% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 24 July 2026.
Does Elantas Beck India Ltd have too much debt?
No — Elantas Beck India Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill north of 100×. FY25 borrowings were ₹0.0 Cr against equity of ₹1,008 Cr. The returns on this page are earned, not borrowed — as of 24 July 2026.
What is Elantas Beck India Ltd's capex?
Elantas Beck India Ltd spent ₹185 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹27.0 Cr, with ₹8.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is Elantas Beck India Ltd's cash flow?
Elantas Beck India Ltd generated ₹127 Cr of operating cash flow in FY25 and ₹100 Cr of free cash flow after ₹27.0 Cr of capital spending. Reported profit that year was ₹148 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Elantas Beck India Ltd's profit real cash?
Mostly — over the last 3 fiscal years, 76% of Elantas Beck India Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹127 Cr against reported profit of ₹148 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 24 July 2026.
Where is Elantas Beck India Ltd in its business cycle?
Elantas Beck India Ltd's FY25 operating margin was 20.0%, against a 12-year band of 12.0%–22.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 20.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Elantas Beck India Ltd story?
The sharpest disagreement: annual EPS moved +5.9% against a −33.5% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Elantas Beck India Ltd a stock worth studying right now?
This is not investment advice. The machine read: Elantas Beck India Ltd's earnings have outrun its stock. EPS grew +5.9% in a year against a −33.5% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.